Verition Fund Management »

4d Molecular Therapeutics In shares owned by Verition Fund Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $827k 39k 20.99
2023-09-30 $2.1M 167k 12.73
2023-06-30 $1.3M 73k 18.07

More positions owned by Verition Fund Management

NVIDIA Corporation Put Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Powerschool Holdings Com Cl A
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Broadcom Call Option (AVGO)
Advanced Micro Devices (AMD)
Arm Holdings Sponsored Ads Put Option (ARM)
Paypal Holdings (PYPL)
Ishares Tr Russell 2000 Etf (IWM)
Coinbase Global Com Cl A Put Option (COIN)
Starbucks Corporation Put Option (SBUX)
Duke Energy Corp Com New Call Option (DUK)
First Solar (FSLR)

View all positions for Verition Fund Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
VR Adviser
Deep Track Capital
Goldman Sachs Group
Henderson Group
Vanguard Group
State Street Corporation
Novo A/S
Redmile Group
Braidwell
Casdin Capital
Geode Capital Management
Polar Capital Holdings

View all funds holding 4d Molecular Therapeutics In